Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias (Peds)
Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias (Children and Young Adults)
Sponsor: Children's Oncology Group
Enrolling: Male and Female Patients
IRB Number: AAAU0227
U.S. Govt. ID: NCT04726241
Contact: Nobuko Hijiya: 212-305-9770 / nh2636@cumc.columbia.edu
Additional Study Information: This study is called a screening study and the purpose of this study to find better ways to diagnose and treat leukemia that has come back after treatment or difficult to treat. Bone marrow, blood, and medical information about cancer and treatment will be collected. The results from this screening study may give other information about leukemia that is important when deciding how to best treat leukemia.
This study is closed
Investigator
Nobuko Hijiya, MD
Do You Qualify?
Are you, or your child, under the age of 22? Yes No
Have you, or your child, been diagnosed with relapsed leukemia? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Nobuko Hijiya
nh2636@cumc.columbia.edu
212-305-9770